Archive – Multinational Companies

Will the pharmaceutical industry ever kick the kickbacks?

This content was published on Jul 10, 2020 Our regular analysis of what the biggest global companies in Switzerland are up to.

Can big pharma’s money solve the antibiotics crisis?

This content was published on Jul 10, 2020 Big pharmaceutical companies are investing nearly $1 billion in a fund to bring new antibiotics to patients. What's the catch?

Tour group blames coronavirus for 70 Swiss job cuts

This content was published on Jul 8, 2020 German tour operator TUI is to close eight of its 62 branches in Switzerland with the loss of around 70 jobs, owing to the effects of the coronavirus crisis.

Cost of economic crime doubled in Switzerland last year

This content was published on Jul 6, 2020 The latest annual report on economic crime by KPMG found that the average amount stolen in each crime spiraled from CHF3.3 million in 2018 to CHF7.7 million last year. The number of fraud cases in excess of CHF10 million rose from four in 2018 to nine last year. There was also a 30% increase in…

Novartis pays big fine for bribing doctors in the US

This content was published on Jul 2, 2020 Swiss pharma company Novartis will pay $729 million to US authorities in an out-of-court settlement over charges that the company bribed doctors to use its drugs.

Studies suggest minimal negative impact of EFTA-Mercosur free trade deal

This content was published on Jun 30, 2020 Two studies commissioned by the Swiss government forecast little to no negative environmental or agricultural impact of the free trade deal.

How Switzerland’s ABB plans to shake off ugly duckling image

This content was published on Jun 30, 2020 The first job Björn Rosengren ever applied for was an internship at manufacturer Asea. Now, at 61, he has been appointed to run the sprawling multinational it grew into: ABB.

SWISS slowly expands web of destinations from Zurich and Geneva

This content was published on Jun 29, 2020 Swiss International Air Lines (SWISS) has published its flight schedules up to October 24, the end of the summer timetable.

A Swiss-Japanese alliance that has thrived in the crisis

This content was published on Jun 24, 2020 Merger or partnership? How the 18-year-old “strategic alliance” between pharma giant Roche and Japanese biotech firm Chugai works.

Swiss gold industry oversight too weak, say auditors

This content was published on Jun 23, 2020 Most of the world’s gold passes through Switzerland to be transformed from raw material and refined. It’s a business that can range in value between CHF60 and CHF90 billion ($70-90 billion) every year. Refineries insist they check the origins of the gold they receive to make sure it comes from well-regulated mines that respect human…

Page 95 of 119

First … 93 94 95 96 97 … Last

Archive – Multinational Companies

Popular Stories

Most Discussed

Archive – Multinational Companies

More

Will the pharmaceutical industry ever kick the kickbacks?

More

Can big pharma’s money solve the antibiotics crisis?

More

Tour group blames coronavirus for 70 Swiss job cuts

More

Cost of economic crime doubled in Switzerland last year

More

Novartis pays big fine for bribing doctors in the US

More

Studies suggest minimal negative impact of EFTA-Mercosur free trade deal

More

How Switzerland’s ABB plans to shake off ugly duckling image

More

SWISS slowly expands web of destinations from Zurich and Geneva

More

A Swiss-Japanese alliance that has thrived in the crisis

More

Swiss gold industry oversight too weak, say auditors

Popular Stories

Most Discussed